Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.50
+0.15 (1.12%)
Dec 20, 2024, 4:00 PM EST - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $348.00 million as of December 20, 2024.
Market Cap
348.00M
Enterprise Value
134.70M
1-Year Change
n/a
Ranking
Category
Stock Price
13.50
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $348.00M, a decrease of -13.45%. That is a compound annual growth rate of -18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 348.00M | -13.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 357.23M |
| Jupiter Neurosciences | 357.04M |
| Prime Medicine | 355.99M |
| AngioDynamics | 348.64M |
| Kamada | 344.88M |
| Design Therapeutics | 339.16M |
| Valneva SE | 337.82M |
| Absci | 335.38M |